IDO1 inhibits ferroptosis by regulating FTO-mediated m6A methylation and SLC7A11 mRNA stability during glioblastoma progression
Qianting Tian,
No information about this author
Guixue Dan,
No information about this author
Xuyan Wang
No information about this author
et al.
Cell Death Discovery,
Journal Year:
2025,
Volume and Issue:
11(1)
Published: Jan. 25, 2025
Language: Английский
Therapeutic Potential of FTO Demethylase in Metabolism and Disease Pathways
Chaitanya Sree Somala,
No information about this author
S. Sathyapriya,
No information about this author
Nagaraj Bharathkumar
No information about this author
et al.
The Protein Journal,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 9, 2025
Language: Английский
Exploring m6A modifications in gastric cancer: from molecular mechanisms to clinical applications
Penghui Li,
No information about this author
Xiangjie Fang,
No information about this author
Di Huang
No information about this author
et al.
European journal of medical research,
Journal Year:
2025,
Volume and Issue:
30(1)
Published: Feb. 12, 2025
The
significance
of
m6A
modifications
in
several
biological
processes
has
been
increasingly
recognized,
particularly
the
context
cancer.
For
instance,
gastric
cancer
(GC)
have
significantly
implicated
tumor
progression,
metastasis,
and
treatment
resistance.
GC
is
characterized
by
differential
expression
regulators.
High
writers
such
as
METTL3
WTAP
are
associated
with
poor
prognosis
aggressive
clinical
features.
Conversely,
low
METTL14
linked
to
worse
outcomes,
whereas
elevated
levels
demethylases,
FTO
ALKBH5,
correlate
better
survival
rates.
These
regulators
influence
cellular
functions,
including
proliferation,
invasion,
migration,
glycolysis,
chemotherapy
resistance,
thereby
affecting
growth
therapeutic
outcomes.
assessment
modification
patterns
profiles
m6A-related
genes
hold
substantial
potential
for
improving
diagnosis
GC.
In
this
review,
we
provide
an
updated
comprehensive
summary
role
GC,
emphasizing
their
molecular
mechanisms,
significance,
translational
applications
developing
novel
diagnostic
strategies.
Language: Английский
Morin induces autophagy-dependent ferroptosis in colorectal cancer cells by inhibiting the AURKB-UCHL3 interactions
Rui Li,
No information about this author
Sha He,
No information about this author
Fengxia Wang
No information about this author
et al.
Cellular Signalling,
Journal Year:
2025,
Volume and Issue:
unknown, P. 111875 - 111875
Published: May 1, 2025
Language: Английский
The Role of M6A LncRNA Modification in Papillary Thyroid Cancer
Michelle S. Klausner,
No information about this author
Caylee A. Greenberg,
No information about this author
Kaleb Noruzi
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(7), P. 2833 - 2833
Published: March 21, 2025
Thyroid
Cancer
(TC)
is
the
most
common
endocrine
cancer,
of
which
papillary
thyroid
cancer
(PTC),
a
well-differentiated
type
TC,
accounts
for
80–90%.
Long
non-coding
RNAs
(lncRNAs),
comprise
non-protein-coding
segments
genome,
have
been
found
to
play
crucial
role
in
various
biological
processes,
including
development.
The
activity
lncRNAs
modified
through
epigenetic
modifications,
with
N6-Methyladenosine
(m6A)
modifications
implicated
progression
several
malignancies.
m6A
further
regulated
by
modifying
enzymes
classified
as
“readers”,
writers”,
and
“erasers”,
specific
aspects
PTC.
Recent
research
has
highlighted
significance
modification
regulating
expression
function
associated
PTC
pathogenesis.
Dysregulation
this
process
implicates
tumor
proliferation,
invasion,
metastasis,
subsequent
impact
on
prognosis.
Therefore,
understanding
interplay
between
provides
valuable
insights
into
molecular
mechanisms
underlying
progression.
This
narrative
review
aims
explore
established
prominent
pathogenesis
seeks
clarify
these
Language: Английский